Sure, here is the description with all links and additional text removed: If you found this video enjoyable, kindly show your ...

Khaberni - Researchers at the University of California revealed that a week-long program combining meditation and other ...

A first-of-its-kind study led by the Medical University of South Carolina raises questions about the value of fish oil ...

Absolute Motivation offers original speeches from excellent speakers designed to provide the motivation, knowledge, and boost ...

A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...

Kazia Therapeutics is paying $1.4 million upfront to secure a platform for generating epigenetic drugs from an Australian research institute. Brisbane-based QIMR Berghofer develop ...

In April 2026, XellSmart officially launches its multicenter Phase II registrational clinical trial of the "Clinical-Grade, Allogeneic, Off-the-Shelf, iPSC-Derived, Dopaminergic Neural Progenitor Cell ...

What if sound waves succeed where drugs failed? Focused ultrasound shows promise in treating Alzheimer's-safe, effective, and ...

Kazia Therapeutics Limited , a clinical-stage oncology company advancing therapies to reprogram cancer biology and overcome treatment resistance, announces the in-licensing of a first-in-class ...

Researchers say knowing that semaglutide improves liver health independently of weight loss could influence prescribing decisions.

Funding to support the Phase 1 clinical trial of ER-100 in optic neuropathies and further investigation of new candidates from the company’s Partial Epigenetic Reprogramming platform ...

The Behavior Change Coach launches specialized hypnotherapy program targeting vaping addiction with proven behavioral ...